

Tadalista 20 Mg
$91.00 – $216.00Price range: $91.00 through $216.00
Pack Size | Price | Add to Cart | Unit Price |
---|---|---|---|
100-tablets | $91.00 | Add to Cart | $0.91 |
150-tablets | $133.00 | Add to Cart | $0.89 |
200-tablets | $174.00 | Add to Cart | $0.87 |
250-tablets | $216.00 | Add to Cart | $0.86 |
Description
Tadalista 20 mg is a trusted generic medication containing Tadalafil as its active ingredient. It is widely used to treat erectile dysfunction (ED) in men by improving blood flow to the penis, ensuring a firm and long-lasting erection. As a cost-effective alternative to branded Cialis, Tadalista 20 mg offers the same therapeutic benefits at an affordable price.
Key Benefits of Tadalista 20 mg
✔ Long-lasting effects – Up to 36 hours of performance support.
✔ Fast action – Starts working in 30-45 minutes.
✔ Enhanced sexual confidence – Reliable results for spontaneity.
✔ Affordable & high-quality – A budget-friendly ED solution.
How Does Tadalista 20 mg Work?
Tadalafil, the active component, inhibits the PDE5 enzyme, allowing increased blood circulation to the penile region upon sexual stimulation. This mechanism helps achieve and sustain a strong erection, improving sexual performance.
Recommended Dosage
- Take one tablet (20 mg) with water, 30-60 minutes before sexual activity.
- Avoid excessive alcohol or fatty meals for optimal results.
- Do not exceed one dose in 24 hours.
Possible Side Effects
Common side effects may include headache, dizziness, flushing, or indigestion. These are usually mild and temporary. If severe reactions occur (e.g., prolonged erection, vision changes), seek medical help immediately.
Precautions & Warnings
- Not recommended for men with heart conditions or on nitrates.
- Consult a doctor before use if you have liver/kidney issues.
- Keep out of reach of children.
Additional information
Dosage |
20mg |
---|---|
Package |
100 Tablet's ,150 Tablet's ,200 Tablet's ,250 Tablet's |
Generic Name |
Tadalafil |
USA Brand Name |
Cialis |
Reviews
Clear filtersThere are no reviews yet.